Tennessee halts Christa Pike's execution after two doses of pentobarbital fail to stop her heart

Christa Pike was still alive after Tennessee gave her both doses of pentobarbital on Wednesday night at the Riverbend Maximum Security Institution in Nashville. Her lawyers said she had a heartbeat and was snoring. The Department of Correction said it followed the protocol approved by the attorney general, that the protocol does not allow further steps, and that she was taken to an off-site hospital.

Pike, 50, is the only woman on the state's death row. She was convicted of murdering a classmate, Colleen Slemmer, in 1995, when Pike was 18, and sentenced to death. Wednesday was meant to be the first execution of a woman in Tennessee in more than 200 years. It became the state's second failed lethal injection this year.

The day in court, then the two syringes

The legal path flipped twice. Around 9 a.m., an hour before the original schedule, the U.S. Court of Appeals for the Sixth Circuit granted a temporary stay. The Tennessee attorney general's office went straight to the U.S. Supreme Court. The court vacated the stay at about 5:50 p.m. in a 6-3 decision, and the execution window reopened. By shortly after 8 p.m. the Knoxville Federal Public Defender's Office said both doses had been given and her heart had not stopped. The office filed in federal district court and in the Tennessee Supreme Court for a stay and for an order that correction staff take steps to keep her alive.

Journalists who watched described a procedure that did not go quiet. They reported snoring, complaints of pain, and kicking hard enough to knock the sheet off her feet. At points the curtain was closed and they could only hear. The New York Times reported that witnesses heard breathing and snoring throughout. Her lawyers said in a filing that executioners injected both syringes and that she did not lose consciousness. Late Wednesday they said she was at a nearby hospital and that they did not know her condition. Tennessee officials confirmed to a federal judge that she was receiving medical care.

What the department said it could not do

After 11 p.m. the department emailed a statement. It said every step of the lawful protocol had been followed, that the chemical had been consistently effective before, and that the protocol does not allow additional procedures beyond what was carried out. That sentence is the operational fact. Once both syringes were in, the written steps were finished, and the state moved her to a hospital rather than attempt a third dose or another method. The statement did not say she was alive. It said she had been transported. Her lawyers said she was.

Pentobarbital is the single drug in Tennessee's current protocol. The state has used it in place of the older three-drug sequence. A failed injection with a drug the department describes as consistently effective leaves an open question the statement does not answer: whether the dose was delivered into a vein, whether the drug was what the label said, or whether something about this case differed from the ones that ended as planned. None of that has been established. The department has not released a timeline of vein access, a record of consciousness checks, or the time between the first syringe and the decision to stop.

The second failure this year

The Nashville Banner noted that this is the second time in a matter of months that a Tennessee execution attempt has failed. That earlier case is why Wednesday's result is not being treated as a one-off equipment fault. Two failures in one year, under the same protocol and the same department, put the attorney general's approval of the written steps under a practical test the approval itself cannot settle. The protocol was followed, the department said, and the person on the gurney was still breathing.

Pike's condition on Thursday morning had not been released by the hospital or the department. Her lawyers were still seeking a formal bar on any further attempt. The murder conviction stands. Slemmer was killed in 1995. The open question is narrower: whether Tennessee will try again with the same two-syringe protocol, and what a court will require the department to show about Wednesday night before it does.